Nilotinib EP Impurity H
Impureza
Esta molécula é um impureza de Nilotinib.

Em Estoque
Impureza
Nilotinib EP Impurity H
Cat. No. ANT-NLT-005CAS 641571-15-5Em Estoque
Dados Técnicos
Cat. No.ANT-NLT-005
CAS641571-15-5
Fórmula Mol.C28H22F3N7O
Peso Mol.529.52 g/mol
IUPAC4-methyl-N-[3-(5-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
SMILESCC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=NC=C3C)NC4=NC=CC(=N4)C5=CN=CC=C5
InChIInChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-34-9-7-24(36-27)20-4-3-8-32-15-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-16-33-14-18(38)2/h3-16H,1-2H3,(H,35,39)(H,34,36,37)
Chave InChILVVDYLLEWIHKDY-UHFFFAOYSA-N
Pureza99%
Somente para uso analítico e de pesquisa — não destinado ao consumo humano ou veterinário.
Descrição
Visão geral
Nilotinib EP Impurity H, Nilotinib, 641571-15-5, 4-methyl-N-[3-(5-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
A Anant Labs é a renomada e autêntica fabricante e fornecedora de Nilotinib EP Impurity H na Índia.
A Anant tem expertise em química orgânica sintética e análise farmacêutica e fornece serviços de pesquisa personalizados com custo acessível e precisão para a indústria.
Sinônimos
4-Methyl-N-(3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamideNilotinib Regio Isomer641571-15-5UNII-N96A6U3MBCN96A6U3MBC4-Methyl-N-(3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamideBenzamide, 4-methyl-N-(3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-Nilotinib Impurity 64-Methyl-N-[3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamideBenzamide, 4-methyl-N-[3-(5-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
Ações Rápidas
Resumo do Produto
NameNilotinib EP Impurity H
Cat. No.ANT-NLT-005
CAS641571-15-5
StatusEm Estoque





